Alendronate
NDC 10135-719, Alendronate sodium tablet, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-719
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA090258
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-719 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ALENDRONATE SODIUM70 mg/1
Pharmacologic classes
Bisphosphonate [EPC]; Diphosphonates [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-719-12 | 10135071912 | 3 BLISTER PACK in 1 CARTON (10135-719-12) / 4 TABLET in 1 BLISTER PACK |
| 10135-719-20 | 10135071920 | 2 BLISTER PACK in 1 CARTON (10135-719-20) / 10 TABLET in 1 BLISTER PACK |
| 10135-719-44 | 10135071944 | 1 BLISTER PACK in 1 CARTON (10135-719-44) / 4 TABLET in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b63421af-ec03-1de7-e053-2a95a90abec6
Use it
Look up 10135-719 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-719 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-719. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.